We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laser Technology Could Advance Thyroid Cancer Screening

By HospiMedica International staff writers
Posted on 28 Mar 2016
A new, low-cost device could enable enhanced information and better diagnosis during thyroid nodule screening. More...


A multidisciplinary team that includes The Institute for Photonic Sciences (ICFO; Barcelona, Spain), Politecnico di Milano (Milan, Italy), the University of Birmingham (United Kingdom), along with five other European institutions, are collaborating on the laser and ultrasound co-analyzer for thyroid nodules (LUCA) project, which combines two photonics systems, near-infrared (NIR) diffuse correlation spectroscopy and time-resolved spectroscopy, along with a ultrasound system and a probe that enables multimodal data acquisition.

The project, launched to enhance screening of thyroid nodules for thyroid cancer, brings together clinical endocrinologists, radiologists, physicists, engineers, and industry players with the intention of developing a low-cost, point-of-care clinical device. According to the project partners, LUCA represents an innovative new tool for cancer diagnosis, screening, and therapy, and as such could have a significant impact not only in the field of thyroid cancer, but also in additional areas of the body accessible to both techniques.

“The device combines ultrasound and near-infrared diffuse optical technologies in a single device and a probe. By combining information about tissue hemodynamics, chemical constitution as well as anatomy, it will overcome the shortcomings of present techniques while screening for malign thyroid nodules,” said Prof. Turgut Durduran, PhD, of the ICFO, scientific coordinator of LUCA. “If successful, this will save millions of euros over the coming decades and improve the lives of millions of Europeans.”

“A new tool made concomitantly with thyroid ultrasound may provide additional information to help us distinguish between benign and malignant nodules,” said Mireia Mora, MD, of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS; Barcelona, Spain), responsible for the clinical application of the tool. “This would allow a reduction in the number of surgeries for these reasons, and would have an important socio-economic impact, diminishing the number of surgeries and the associated comorbidities, as well as improving the quality of life of the patients affected.”

Thyroid nodules are a common pathology, with a prevalence of around 5% in women and 1% in men, which increases to 19%–76% with diagnostic neck ultrasound. To exclude thyroid cancer when screening—which occurs in 5%–15% of cases—ultrasound is followed by fine-needle aspiration biopsy of suspicious nodules. In thyroid cancer, the sensitivity and specificity of this process are limited, with a large number of non-diagnostic and false positive results that lead to unnecessary surgery.

Related Links:

Photonic Sciences
Politecnico di Milano
University of Birmingham



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Anatomically guided sonography for trauma assessment includes a mixed reality headset (e.g., top left). Example views show virtual augmentation overlays for anatomy registration and ultrasound probe guidance on a test surrogate. The anatomical display is customized based on the organ or region being targeted with the ultrasound probe. (Robert S. Armiger, Anna E. Knight, Catherine M. Carneal, et al. Journal of Medical Imaging (2026). DOI: 10.1117/1.jmi.13.4.045001)

Anatomical Guidance System Improves Trauma Ultrasound Acquisition by Novice Users

Focused assessment with sonography for trauma (FAST) helps clinicians detect free fluid and signs of internal bleeding in injured patients, but obtaining reliable images can be difficult for inexperienced operators.... Read more

Surgical Techniques

view channel
Image: MIT researchers have developed a handheld device capable of gently collecting living cells from specific locations to test for ovarian and many other types of cancer. (Photo courtesy of Kripa Varanasi, et al)

Handheld Device Improves Targeted Cell Collection for Early Ovarian Cancer Assessment

High-grade serous ovarian cancer is the most common form of ovarian cancer, and many cases are thought to originate in the fallopian tubes. Because precursor lesions can be microscopic, they are difficult... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.